{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:34:57Z","timestamp":1774928097077,"version":"3.50.1"},"reference-count":30,"publisher":"Japan Oil Chemists' Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2010]]},"DOI":"10.5650\/jos.59.423","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T14:18:02Z","timestamp":1307110682000},"page":"423-430","source":"Crossref","is-referenced-by-count":21,"title":["Preparation of Ophthalmic Formulations Containing Cilostazol as an Anti-glaucoma Agent and Improvement in Its Permeability through the Rabbit Cornea"],"prefix":"10.5650","volume":"59","author":[{"given":"Norio","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Murao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Kurimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3621","reference":[{"key":"1","unstructured":"1. Armaly, M. F.; Krueger, D. E.; Maunder, L.; Becker, B.; Hetherington, J.Jr.; Kolker, A. E.; Levene, R. Z.; Maumenee, A. E.; Pollack, I. P.; Shaffer, R. N. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch. Ophthalmol. 98, 2163-2171 (1980)."},{"key":"2","unstructured":"2. Quigley, H. A.; Addicks, E. M.; Green, W. R.; Maumenee, A. E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch. Ophthalmol. 99, 635-649 (1981)."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4835(89)80060-0"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00012-0"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0832"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(89)90049-3"},{"key":"7","unstructured":"7. Oshika, T.; Araie, M.; Sugiyama, T.; Nakajima, M., Azuma, I. Effect of bunazosin hydrochloride on intraocular pressure and aqueous humor dynamics in normotensive human eyes. Arch. Ophthalmol. 109, 1569-1574 (1991)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Coakes, R. L.; Brubaker, R. F. The mechanism of timolol in lowering intraocular pressure in the normal eye. Arch. Ophthalmol. 96, 2045-2048 (1978).","DOI":"10.1001\/archopht.1978.03910060433007"},{"key":"9","unstructured":"9. Toris, C. B.; Gleason, M. L.; Camras, C. B.; Yablonski, M. E. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch. Ophthalmol. 113, 1514-1517 (1995)."},{"key":"10","unstructured":"10. Lippa, E. A.; Carlson, L. E.; Ehinger, B.; Eriksson, L. O.; Finnström, K.; Holmin, S. E.; Nyman, K.; Raitta, C.; Ringvoid, A.; Tarkkanen, A.; Vegge, T.; Deasy, D; Holder, D; Ytteborg, J. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch. Ophthalmol. 110, 495-499 (1992)."},{"key":"11","unstructured":"11. Gaasterland, D.; Kupfer, C.; Ross, K. Studies of aquenous humor dynamics in man. IV: Effects of pilocarpine upon measurements in young normal volunteers. Invest. Ophthalmol. 14, 848-853 (1975)."},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304153281507"},{"key":"13","unstructured":"13. Hart, W. M. “Intraocular pressure” Adler’s Physiology of the Eye: Clinical application. 9th edn. (Hart, W. M. ed.). Mosby. St. Lous. pp.248-267 (1992)."},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4835(05)80042-9"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-199802000-00009"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/0959-437X(94)90094-9"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(00)89022-2"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90164-8"},{"issue":"11","key":"19","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/j.1460-2075.1994.tb06550.x","volume":"13","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0261-4189","issn-type":"print"},{"key":"20","unstructured":"20. Honjo, M.; Tanihara, H.; Inatani, M.; Kido, N.: Sawamura, T.; Yue, B.Y.; Narumiya, S.; Honda, Y. Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42, 137-144 (2001)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kambayashi, J.; Liu, Y.; Sun, B.; Shakur, Y.; Yoshitake, M.; Czerwiec, F. CLZ as a unique antithrombotic agent. Curr. Pharm. Des. 9, 22-89-2302 (2003).","DOI":"10.2174\/1381612033453910"},{"issue":"4","key":"22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1248\/yakushi1947.100.4_402","volume":"100","year":"1980","ISSN":"https:\/\/id.crossref.org\/issn\/0031-6903","issn-type":"print"},{"issue":"2","key":"23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1248\/cpb.37.442","volume":"37","author":"OGISO T","year":"1989","ISSN":"https:\/\/id.crossref.org\/issn\/0009-2363","issn-type":"print"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(89)90030-6"},{"key":"25","unstructured":"25. Cirri, M.; Maestrelli, F.; Mennini, N.; Mura, P. Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids. J. Pharm. Biom. Anal. 50, 683-689 (2009)."},{"key":"26","unstructured":"26. Yamaguchi, M.; Isowaki, A.; Ohtori, A.; Ohguro, N.; Takeuchi, H. Formulation design of ophthalmic lipid emulsion for improvement of bioavailability in anterior segment of the eye. Abstract for XVIII International Congress for Eye Research. Beijing. September. p.141 (2008)."},{"key":"27","unstructured":"27. Fuente, D. L. M.; Seijo, B.; Alonso, J. M. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest. Ophthal. Vis. Sci. 49, 2016-2024 (2008)."},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011956327987"},{"key":"29","unstructured":"29. Jansen, T.; Xhonneux, B.; Mesens, J.; Borgers, M. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxic. Res. 7, 459-468 (1990)."},{"key":"30","unstructured":"30. Kashimoto, R.; Kurimoto, T.; Miyoshi, T.; Okamoto, N.; Tagami, Y.; Oono, S.; Ito, Y.; Mimura, O. Cilostazol promotes survival of axotomized retinal ganglion cells in adult rats. Neurosci. Lett. 436, 116-119 (2008)."}],"container-title":["Journal of Oleo Science"],"original-title":[],"link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/59\/8\/59_8_423\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:26:07Z","timestamp":1656555967000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jos\/59\/8\/59_8_423\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.59.423","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"value":"1345-8957","type":"print"},{"value":"1347-3352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}